{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:04:57Z","timestamp":1751515497603,"version":"3.41.0"},"reference-count":28,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BLCTT"],"DOI":"10.2147\/blctt.s549780","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:15:13Z","timestamp":1751447713000},"page":"69-75","source":"Crossref","is-referenced-by-count":0,"title":["Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments [Podcast]"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Amer M","family":"Zeidan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"DiNardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/cells13161392","volume":"13","author":"Nong","year":"2024","journal-title":"Cells"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3322\/caac.21873","volume":"75","author":"Kantarjian","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41375-024-02246-2","volume":"38","author":"Fruchtman","year":"2024","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.6004\/jadpro.2019.10.5.7","volume":"10","author":"Merchant","year":"2019","journal-title":"J Adv Pract Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"Shimony","year":"2023","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.3390\/cancers14123012","volume":"14","author":"Messina","year":"2022","journal-title":"Cancers"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1182\/bloodadvances.2023009854","volume":"7","author":"Venugopal","year":"2023","journal-title":"Blood Adv"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","volume":"378","author":"DiNardo","year":"2018","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1182\/bloodadvances.2022009411","volume":"7","author":"de Botton","year":"2023","journal-title":"Blood Adv"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa2117344","volume":"386","author":"Montesinos","year":"2022","journal-title":"N Engl J Med"},{"key":"ref12","unstructured":"TIBSOVO\u00ae (ivosidenib tablets) [package insert]. Boston, MA: Servier Pharmaceuticals LLC; 2023. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/211192_s008lbl.pdf. Accessed July 28, 2025."},{"key":"ref13","unstructured":"REZLIDHIA\u2122 (olutasidenib capsules, for oral use) [package insert]. South San Francisco, CA: Rigel Pharms; 2022. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/215814s000lbl.pdf. Accessed July 28, 2025."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1080\/10428194.2024.2333451","volume":"65","author":"Cortes","year":"2024","journal-title":"Leuk Lymphoma"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1182\/bloodadvances.2023011914","volume":"8","author":"Montesinos","year":"2024","journal-title":"Blood Adv"},{"key":"ref16","unstructured":"IDHIFA\u00ae (enasidenib tablets, for oral use) [package insert]. Boston, MA: Servier Pharmaceuticals LLC; 2025. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/209606s007lbl.pdf. Accessed July 28, 2025."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/ajh.26142","volume":"96","author":"Fathi","year":"2021","journal-title":"Am J Hematol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1182\/blood.2024024008","volume":"145","author":"Issa","year":"2025","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.3390\/cancers15194767","volume":"15","author":"Woods","year":"2023","journal-title":"Cancers"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1158\/2643-3230.BCD-22-0205","volume":"4","author":"Lachowiez","year":"2023","journal-title":"Blood Cancer Discov"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009391","author":"Bazinet","year":"2023","journal-title":"Blood Adv"},{"key":"ref22","unstructured":"Clinical Trial. HOVON 150 AML\/ AMLSG 29-18. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03839771. Accessed May 5, 2025."},{"key":"ref23","unstructured":"Clinical Trial. HOVON 150 AML\/ AMLSG 29-18. Available from: https:\/\/hovon.nl\/en\/trials\/ho150. Accessed May 5, 2025."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1182\/blood-2024-207476","volume":"144","author":"Croden","year":"2024","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/CCO.0000000000001094","volume":"36","author":"Travaglini","year":"2024","journal-title":"Curr Opin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"117788","DOI":"10.1016\/j.biopha.2024.117788","volume":"182","author":"Rataj","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41408-021-00495-3","volume":"11","author":"Daver","year":"2021","journal-title":"Blood Cancer J"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/s41375-022-01666-2","volume":"36","author":"Ranieri","year":"2022","journal-title":"Leukemia"}],"container-title":["Blood and Lymphatic Cancer: Targets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/104428","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/104428","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:15:15Z","timestamp":1751447715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/deep-dive-into-targeted-therapies-understanding-idh1-mutant-aml-treatm-peer-reviewed-fulltext-article-BLCTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":28,"URL":"https:\/\/doi.org\/10.2147\/blctt.s549780","relation":{},"ISSN":["1179-9889"],"issn-type":[{"value":"1179-9889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}